Received: 13 July 2022
Accepted: 19 October 2022
First Online: 17 November 2022
: This retrospective study received IRB approval from the IRB of the University of Kentucky and the study adhered to the tenets of the declaration of Helsinki. All of the information and data collected was in accordance with the Health Insurance Portability and Accountability Act (HIPAA).
: Not applicable.
: CAT, MAJ, NF, RH, EA, JBC, GK, HRJ, SVR and MMA have no competing interests. RSM is a consultant with ProQR Therapeutics.